InspireMD Inc NSPR
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2013-04-12 |
| Shares Out. | 46,840,000 |
| Website | inspiremd.com/en/ ↗ |
| Phone | 13026587581 |
| Employees | 127 |
| Revenue | $3.4M |
| Gross Profit | $687,000 |
| Net Income | -$13.7M |
| Free Cash Flow | -$40.1M |
| Total Assets | $56.5M |
| Total Liabilities | $12.9M |
| Equity | $43.6M |
About InspireMD Inc
InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.
InspireMD Inc is a publicly traded company under the ticker symbol NSPR on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
9 analysts (2026-07-01)